- Home
- APLS vs BLKB Comparison
APLS vs BLKB Comparison
Compare APLS & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- BLKB
- Stock Information
- Founded
- APLS 2009
- BLKB 1981
- Country
- APLS United States
- BLKB United States
- Employees
- APLS N/A
- BLKB N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- BLKB Computer Software: Prepackaged Software
- Sector
- APLS Health Care
- BLKB Technology
- Exchange
- APLS Nasdaq
- BLKB Nasdaq
- Market Cap
- APLS 3.5B
- BLKB 3.2B
- IPO Year
- APLS 2017
- BLKB 2004
- Fundamental
- Price
- APLS $27.97
- BLKB $66.46
- Analyst Decision
- APLS Buy
- BLKB Hold
- Analyst Count
- APLS 20
- BLKB 3
- Target Price
- APLS $34.11
- BLKB $78.67
- AVG Volume (30 Days)
- APLS 3.0M
- BLKB 399.7K
- Earning Date
- APLS 07-31-2025
- BLKB 07-30-2025
- Dividend Yield
- APLS N/A
- BLKB N/A
- EPS Growth
- APLS N/A
- BLKB N/A
- EPS
- APLS N/A
- BLKB N/A
- Revenue
- APLS $754,649,000.00
- BLKB $1,141,002,000.00
- Revenue This Year
- APLS $10.84
- BLKB N/A
- Revenue Next Year
- APLS $10.51
- BLKB $4.03
- P/E Ratio
- APLS N/A
- BLKB N/A
- Revenue Growth
- APLS 20.02
- BLKB 0.16
- 52 Week Low
- APLS $16.10
- BLKB $58.05
- 52 Week High
- APLS $41.94
- BLKB $88.95
- Technical
- Relative Strength Index (RSI)
- APLS 74.59
- BLKB 57.46
- Support Level
- APLS $26.23
- BLKB $63.77
- Resistance Level
- APLS $28.87
- BLKB $65.42
- Average True Range (ATR)
- APLS 1.07
- BLKB 1.84
- MACD
- APLS 0.18
- BLKB 0.23
- Stochastic Oscillator
- APLS 84.04
- BLKB 93.48
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.